Since the introduction of generic drugs in 2001, Brazil’s pharmaceutical industry has undergone a transformation. Generic drugs have been continuously gaining market share and currently account for a significant share of the total pharmaceutical market in Brazil. According to estimates, around BRL 2 Billion worth of branded drugs are expected to lose patent protection during the next five years. The high potential of generic drugs is also driven by the fact that despite strong growth in recent years, the penetration of generics still remains low compared to mature markets such as Germany, the United States, the United Kingdom, etc. These factors along with a rising ageing population, increasing prevalence of life style diseases and the significant cost savings achieved from the use of generic drugs are expected to drive this market during the next five years.
The report entitled “Brazil Generic Drug Market: Industry Trends, Share, Size, Growth, Forecast and Opportunity 2021-2026” represents an in-depth analysis on the historical, current and future trends in the generic drug market in Brazil. This research report serves as an exceptional tool to understand the drivers, sales trends, volume trends, market structure, competitive landscape, regulations, key players, manufacturing and the outlook of generic drugs in Brazil. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who want to gain an insight into the market for generic drugs in Brazil.
Key Questions Answered in this Report:
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at